Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.
暂无分享,去创建一个
W. Seeger | H. Ghofrani | F. Grimminger | R. Schermuly | F. Reichenberger | T. Gessler | R. Voswinckel | H. Gall | T. Schmehl | H. Olschewski | L. Rubin | S. Krick | M. Kohstall | B. Enke | A. Kreckel
[1] Horst Olschewski,et al. Inhaled Treprostinil for Treatment of Chronic Pulmonary Arterial Hypertension , 2006 .
[2] W. Seeger,et al. Inhaled trepostinil for treatment of chronic pulmonary arterial hypertension. Author's reply , 2006 .
[3] R. Benza,et al. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. , 2005, American Journal of Respiratory and Critical Care Medicine.
[4] T. Hunt,et al. Pharmacokinetics and Steady-State Bioequivalence of Treprostinil Sodium (Remodulin®) Administered by the Intravenous and Subcutaneous Route to Normal Volunteers , 2004, Journal of cardiovascular pharmacology.
[5] S. Rich,et al. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. , 2004, Chest.
[6] L. Rubin,et al. Pulmonary arterial hypertension: a look to the future. , 2004, Journal of the American College of Cardiology.
[7] R. Barst,et al. Prostanoid therapy for pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[8] T. Hunt,et al. Pharmacokinetics of Treprostinil Sodium Administered by 28‐Day Chronic Continuous Subcutaneous Infusion , 2004, Journal of clinical pharmacology.
[9] W. Seeger,et al. Prostacyclin and its analogues in the treatment of pulmonary hypertension. , 2004, Pharmacology & therapeutics.
[10] T. Hunt,et al. Absolute Bioavailability and Pharmacokinetics of Treprostinil Sodium Administered by Acute Subcutaneous Infusion , 2004, Journal of clinical pharmacology.
[11] H. Ghofrani,et al. Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension. , 2003, Chest.
[12] S. Rich,et al. Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension , 2003, Journal of cardiovascular pharmacology.
[13] W. Seeger,et al. Inhaled iloprost for severe pulmonary hypertension. , 2002, The New England journal of medicine.
[14] S. Rich,et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.
[15] T. Kaptchuk. The double-blind, randomized, placebo-controlled trial: gold standard or golden calf? , 2001, Journal of clinical epidemiology.
[16] S. Narumiya,et al. Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.